

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal absorption (GO:0050892) | 8.80760914 |
| 2 | intestinal cholesterol absorption (GO:0030299) | 7.40479082 |
| 3 | angiotensin maturation (GO:0002003) | 6.86287279 |
| 4 | flavonoid metabolic process (GO:0009812) | 5.69437217 |
| 5 | NADH metabolic process (GO:0006734) | 5.65182604 |
| 6 | bile acid and bile salt transport (GO:0015721) | 5.57071688 |
| 7 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.43971533 |
| 8 | actin filament depolymerization (GO:0030042) | 5.31483946 |
| 9 | vitamin A metabolic process (GO:0006776) | 5.29351508 |
| 10 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 5.19620676 |
| 11 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 5.19620676 |
| 12 | epoxygenase P450 pathway (GO:0019373) | 5.08511287 |
| 13 | fat-soluble vitamin biosynthetic process (GO:0042362) | 5.06910770 |
| 14 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.94904294 |
| 15 | endocrine process (GO:0050886) | 4.94904294 |
| 16 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.94904294 |
| 17 | digestive system process (GO:0022600) | 4.83976811 |
| 18 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.75721414 |
| 19 | sulfate transmembrane transport (GO:1902358) | 4.72768890 |
| 20 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.46838617 |
| 21 | fructose metabolic process (GO:0006000) | 4.46541403 |
| 22 | regulation of systemic arterial blood pressure (GO:0003073) | 4.44743788 |
| 23 | sulfation (GO:0051923) | 4.38410927 |
| 24 | intestinal epithelial cell development (GO:0060576) | 4.34215111 |
| 25 | regulation of cellular extravasation (GO:0002691) | 4.27667365 |
| 26 | drug catabolic process (GO:0042737) | 4.18323188 |
| 27 | epithelial structure maintenance (GO:0010669) | 4.15781680 |
| 28 | regulation of bile acid biosynthetic process (GO:0070857) | 4.08795661 |
| 29 | renal system process involved in regulation of blood volume (GO:0001977) | 4.08655848 |
| 30 | cellular glucuronidation (GO:0052695) | 4.06919405 |
| 31 | urea cycle (GO:0000050) | 4.03702024 |
| 32 | sperm capacitation (GO:0048240) | 4.02882862 |
| 33 | drug metabolic process (GO:0017144) | 4.01824985 |
| 34 | glucuronate metabolic process (GO:0019585) | 3.99594424 |
| 35 | uronic acid metabolic process (GO:0006063) | 3.99594424 |
| 36 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.97033297 |
| 37 | virion attachment to host cell (GO:0019062) | 3.96818840 |
| 38 | adhesion of symbiont to host cell (GO:0044650) | 3.96818840 |
| 39 | bicarbonate transport (GO:0015701) | 3.93208550 |
| 40 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.91878224 |
| 41 | peptide catabolic process (GO:0043171) | 3.91590748 |
| 42 | protein-lipid complex remodeling (GO:0034368) | 3.91518786 |
| 43 | macromolecular complex remodeling (GO:0034367) | 3.91518786 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 3.91518786 |
| 45 | high-density lipoprotein particle remodeling (GO:0034375) | 3.90146157 |
| 46 | urea metabolic process (GO:0019627) | 3.88336219 |
| 47 | plasma lipoprotein particle organization (GO:0071827) | 3.87928455 |
| 48 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.84763401 |
| 49 | sulfur compound transport (GO:0072348) | 3.83457177 |
| 50 | regulation of cGMP biosynthetic process (GO:0030826) | 3.80160926 |
| 51 | sulfate transport (GO:0008272) | 3.79429052 |
| 52 | positive regulation of pseudopodium assembly (GO:0031274) | 3.78912602 |
| 53 | low-density lipoprotein particle remodeling (GO:0034374) | 3.73363652 |
| 54 | protein-lipid complex subunit organization (GO:0071825) | 3.70912628 |
| 55 | vocalization behavior (GO:0071625) | 3.68249910 |
| 56 | digestion (GO:0007586) | 3.65286961 |
| 57 | regulation of guanylate cyclase activity (GO:0031282) | 3.62440568 |
| 58 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.61528485 |
| 59 | O-glycan processing (GO:0016266) | 3.60753246 |
| 60 | regulation of vitamin metabolic process (GO:0030656) | 3.56578780 |
| 61 | positive regulation of respiratory burst (GO:0060267) | 3.55770390 |
| 62 | sodium ion export (GO:0071436) | 3.55516914 |
| 63 | nitrogen cycle metabolic process (GO:0071941) | 3.53969852 |
| 64 | positive regulation of lipid catabolic process (GO:0050996) | 3.50363344 |
| 65 | glucose 6-phosphate metabolic process (GO:0051156) | 3.49604234 |
| 66 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.45161664 |
| 67 | peptide hormone processing (GO:0016486) | 3.44756568 |
| 68 | thyroid hormone metabolic process (GO:0042403) | 3.44104314 |
| 69 | desmosome organization (GO:0002934) | 3.43219478 |
| 70 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.42297667 |
| 71 | ethanol oxidation (GO:0006069) | 3.41837920 |
| 72 | modified amino acid transport (GO:0072337) | 3.41767821 |
| 73 | response to hepatocyte growth factor (GO:0035728) | 3.40547398 |
| 74 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 3.40547398 |
| 75 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.40186784 |
| 76 | phospholipid efflux (GO:0033700) | 3.39480902 |
| 77 | reverse cholesterol transport (GO:0043691) | 3.38734927 |
| 78 | regulation of pseudopodium assembly (GO:0031272) | 3.36754700 |
| 79 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.36022570 |
| 80 | cholesterol efflux (GO:0033344) | 3.34856064 |
| 81 | complement activation, classical pathway (GO:0006958) | 3.33437727 |
| 82 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.29130242 |
| 83 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.28225627 |
| 84 | phosphatidylcholine biosynthetic process (GO:0006656) | 3.24161970 |
| 85 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.23850335 |
| 86 | drinking behavior (GO:0042756) | 3.21750450 |
| 87 | regulation of viral release from host cell (GO:1902186) | 3.21232804 |
| 88 | arginine metabolic process (GO:0006525) | 3.20816648 |
| 89 | cellular potassium ion homeostasis (GO:0030007) | 3.20685257 |
| 90 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.20289839 |
| 91 | cell communication involved in cardiac conduction (GO:0086065) | 3.20098654 |
| 92 | regulation of triglyceride catabolic process (GO:0010896) | 3.17515298 |
| 93 | plasma lipoprotein particle assembly (GO:0034377) | 3.16516416 |
| 94 | glycosphingolipid catabolic process (GO:0046479) | 3.15638741 |
| 95 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.14434168 |
| 96 | glycolipid catabolic process (GO:0019377) | 3.14230545 |
| 97 | drug transport (GO:0015893) | 3.12709823 |
| 98 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.12297846 |
| 99 | adhesion of symbiont to host (GO:0044406) | 3.11600058 |
| 100 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.11137957 |
| 101 | regulation of actin nucleation (GO:0051125) | 3.10844110 |
| 102 | hormone catabolic process (GO:0042447) | 3.10583457 |
| 103 | protein-lipid complex assembly (GO:0065005) | 3.09397548 |
| 104 | transcytosis (GO:0045056) | 3.08611812 |
| 105 | regulation of cGMP metabolic process (GO:0030823) | 3.07987145 |
| 106 | diacylglycerol metabolic process (GO:0046339) | 3.07367077 |
| 107 | lipoprotein transport (GO:0042953) | 3.06213300 |
| 108 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.05528583 |
| 109 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.05528583 |
| 110 | drug transmembrane transport (GO:0006855) | 3.05457653 |
| 111 | glomerular filtration (GO:0003094) | 3.04357554 |
| 112 | regulation of cholesterol homeostasis (GO:2000188) | 3.03755773 |
| 113 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.03706817 |
| 114 | GDP-mannose metabolic process (GO:0019673) | 3.03241920 |
| 115 | striated muscle atrophy (GO:0014891) | 3.03034047 |
| 116 | homocysteine metabolic process (GO:0050667) | 3.02897861 |
| 117 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.02371897 |
| 118 | membrane repolarization during action potential (GO:0086011) | 3.02042008 |
| 119 | cGMP-mediated signaling (GO:0019934) | 3.00356205 |
| 120 | thrombin receptor signaling pathway (GO:0070493) | 2.99283116 |
| 121 | sexual reproduction (GO:0019953) | 2.98485481 |
| 122 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.98389607 |
| 123 | negative regulation of sodium ion transport (GO:0010766) | 2.98277675 |
| 124 | bile acid metabolic process (GO:0008206) | 2.98141565 |
| 125 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.97862808 |
| 126 | auditory receptor cell differentiation (GO:0042491) | 2.95309816 |
| 127 | neurotransmitter biosynthetic process (GO:0042136) | 2.95118290 |
| 128 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.94904543 |
| 129 | alkaloid metabolic process (GO:0009820) | 2.94612112 |
| 130 | hemidesmosome assembly (GO:0031581) | 2.93918138 |
| 131 | lipoprotein metabolic process (GO:0042157) | 2.93909127 |
| 132 | vitamin transmembrane transport (GO:0035461) | 2.93160901 |
| 133 | regulation of cholesterol esterification (GO:0010872) | 2.91851040 |
| 134 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.88201991 |
| 135 | regulation of respiratory burst (GO:0060263) | 2.87853851 |
| 136 | cardiac conduction (GO:0061337) | 2.80751154 |
| 137 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.77343169 |
| 138 | antibacterial humoral response (GO:0019731) | 2.77094234 |
| 139 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.73807306 |
| 140 | transepithelial transport (GO:0070633) | 2.73672760 |
| 141 | hepatocyte apoptotic process (GO:0097284) | 2.73032537 |
| 142 | regulation of protein glycosylation (GO:0060049) | 2.72599667 |
| 143 | cytidine metabolic process (GO:0046087) | 2.70263265 |
| 144 | cytidine catabolic process (GO:0006216) | 2.70263265 |
| 145 | cytidine deamination (GO:0009972) | 2.70263265 |
| 146 | ribonucleoside bisphosphate metabolic process (GO:0033875) | 2.68566536 |
| 147 | nucleoside bisphosphate metabolic process (GO:0033865) | 2.68566536 |
| 148 | purine nucleoside bisphosphate metabolic process (GO:0034032) | 2.68566536 |
| 149 | antimicrobial humoral response (GO:0019730) | 2.68349652 |
| 150 | cholesterol homeostasis (GO:0042632) | 2.67876955 |
| 151 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.66953587 |
| 152 | skeletal muscle adaptation (GO:0043501) | 2.65794088 |
| 153 | sterol homeostasis (GO:0055092) | 2.65678782 |
| 154 | response to histamine (GO:0034776) | 2.65168979 |
| 155 | negative regulation of cholesterol transport (GO:0032375) | 2.64386162 |
| 156 | negative regulation of sterol transport (GO:0032372) | 2.64386162 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 6.03547288 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 4.38439653 |
| 3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.11702640 |
| 4 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.76880598 |
| 5 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.31036789 |
| 6 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.28033326 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.15880164 |
| 8 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.13274161 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.12476753 |
| 10 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 2.08071839 |
| 11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.04109159 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.02765835 |
| 13 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.97060975 |
| 14 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.96242042 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.94111409 |
| 16 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.81606829 |
| 17 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.79922313 |
| 18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.73911407 |
| 19 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.71168898 |
| 20 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68068934 |
| 21 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.65079759 |
| 22 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.64163371 |
| 23 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.61249028 |
| 24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.58195511 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.56182625 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.55672644 |
| 27 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.53205077 |
| 28 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.51874610 |
| 29 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.50985806 |
| 30 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.50975555 |
| 31 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.49686300 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47264046 |
| 33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.45480620 |
| 34 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.43043394 |
| 35 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.40518325 |
| 36 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.39815308 |
| 37 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.39008354 |
| 38 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.38263100 |
| 39 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.37477811 |
| 40 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.37048182 |
| 41 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.34929203 |
| 42 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32975248 |
| 43 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.31263246 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.30656432 |
| 45 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.30611178 |
| 46 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29890607 |
| 47 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.28973848 |
| 48 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.28796259 |
| 49 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27813227 |
| 50 | VDR_22108803_ChIP-Seq_LS180_Human | 1.27267520 |
| 51 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25486369 |
| 52 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.25143509 |
| 53 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.24242952 |
| 54 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22506157 |
| 55 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22169080 |
| 56 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.21626013 |
| 57 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.21547321 |
| 58 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.19515170 |
| 59 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19416965 |
| 60 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.19204483 |
| 61 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.18455289 |
| 62 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.18299145 |
| 63 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.12979688 |
| 64 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.12596848 |
| 65 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.12448197 |
| 66 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.11842458 |
| 67 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.11841907 |
| 68 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.11444741 |
| 69 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.11073347 |
| 70 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.11041978 |
| 71 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10516326 |
| 72 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.09919856 |
| 73 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.08176133 |
| 74 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05144123 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.05113987 |
| 76 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05036682 |
| 77 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.04027056 |
| 78 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.04027056 |
| 79 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03466822 |
| 80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.03455648 |
| 81 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03242570 |
| 82 | GATA1_22025678_ChIP-Seq_K562_Human | 1.02702164 |
| 83 | RXR_22108803_ChIP-Seq_LS180_Human | 1.02317850 |
| 84 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01821523 |
| 85 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.01705333 |
| 86 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.00464420 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.99970183 |
| 88 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98932435 |
| 89 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98154502 |
| 90 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.97969999 |
| 91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96932080 |
| 92 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.96648291 |
| 93 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.95982972 |
| 94 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.95817895 |
| 95 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.95563710 |
| 96 | P68_20966046_ChIP-Seq_HELA_Human | 0.95421977 |
| 97 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.95406738 |
| 98 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.95099071 |
| 99 | ATF3_27146783_Chip-Seq_COLON_Human | 0.94977838 |
| 100 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.94350463 |
| 101 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.94203937 |
| 102 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94157740 |
| 103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93199130 |
| 104 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.92957074 |
| 105 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.92177830 |
| 106 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.91681639 |
| 107 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.91134813 |
| 108 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.91000646 |
| 109 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.90998769 |
| 110 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.90627048 |
| 111 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.89622315 |
| 112 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.89348497 |
| 113 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88672562 |
| 114 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88595690 |
| 115 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88367450 |
| 116 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.87291183 |
| 117 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.87273751 |
| 118 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.87092790 |
| 119 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.86266216 |
| 120 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.84941050 |
| 121 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.84777488 |
| 122 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.84677639 |
| 123 | TP53_16413492_ChIP-PET_HCT116_Human | 0.84602047 |
| 124 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.84594576 |
| 125 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84545035 |
| 126 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.84277253 |
| 127 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.83707658 |
| 128 | * BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.83579338 |
| 129 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82787358 |
| 130 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.80921403 |
| 131 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.80877027 |
| 132 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.80451182 |
| 133 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.80315650 |
| 134 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.79828633 |
| 135 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.79345161 |
| 136 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.79197524 |
| 137 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78974385 |
| 138 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.78969203 |
| 139 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.78866315 |
| 140 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.78806289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 7.16459610 |
| 2 | MP0005360_urolithiasis | 6.43175607 |
| 3 | MP0001666_abnormal_nutrient_absorption | 4.83978858 |
| 4 | MP0002822_catalepsy | 4.66261302 |
| 5 | MP0004264_abnormal_extraembryonic_tissu | 3.78973950 |
| 6 | MP0000462_abnormal_digestive_system | 3.41967892 |
| 7 | MP0003866_abnormal_defecation | 3.17362101 |
| 8 | MP0005377_hearing/vestibular/ear_phenot | 3.08134319 |
| 9 | MP0003878_abnormal_ear_physiology | 3.08134319 |
| 10 | MP0003283_abnormal_digestive_organ | 2.71244549 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.51482303 |
| 12 | MP0001663_abnormal_digestive_system | 2.39645310 |
| 13 | MP0002139_abnormal_hepatobiliary_system | 2.38710639 |
| 14 | MP0001664_abnormal_digestion | 2.37943143 |
| 15 | MP0008875_abnormal_xenobiotic_pharmacok | 2.37571124 |
| 16 | MP0003183_abnormal_peptide_metabolism | 2.34803182 |
| 17 | MP0001873_stomach_inflammation | 2.32825206 |
| 18 | MP0005381_digestive/alimentary_phenotyp | 2.31875314 |
| 19 | MP0003252_abnormal_bile_duct | 2.31178291 |
| 20 | MP0005409_darkened_coat_color | 2.24412550 |
| 21 | MP0000537_abnormal_urethra_morphology | 2.06056431 |
| 22 | MP0009840_abnormal_foam_cell | 2.00338117 |
| 23 | MP0010155_abnormal_intestine_physiology | 1.95051996 |
| 24 | MP0000477_abnormal_intestine_morphology | 1.83295895 |
| 25 | MP0005167_abnormal_blood-brain_barrier | 1.82906366 |
| 26 | MP0010329_abnormal_lipoprotein_level | 1.82905514 |
| 27 | MP0004043_abnormal_pH_regulation | 1.81981695 |
| 28 | MP0004270_analgesia | 1.81760849 |
| 29 | MP0000490_abnormal_crypts_of | 1.81237103 |
| 30 | MP0005670_abnormal_white_adipose | 1.76171546 |
| 31 | MP0004019_abnormal_vitamin_homeostasis | 1.64865082 |
| 32 | MP0000538_abnormal_urinary_bladder | 1.51709473 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.50132406 |
| 34 | MP0010678_abnormal_skin_adnexa | 1.49834001 |
| 35 | MP0008872_abnormal_physiological_respon | 1.46169594 |
| 36 | MP0002796_impaired_skin_barrier | 1.43452008 |
| 37 | MP0000566_synostosis | 1.43278638 |
| 38 | MP0001849_ear_inflammation | 1.42459877 |
| 39 | MP0004147_increased_porphyrin_level | 1.40181920 |
| 40 | MP0003315_abnormal_perineum_morphology | 1.35428189 |
| 41 | MP0003879_abnormal_hair_cell | 1.34950936 |
| 42 | MP0009780_abnormal_chondrocyte_physiolo | 1.33287615 |
| 43 | MP0003705_abnormal_hypodermis_morpholog | 1.32770237 |
| 44 | MP0004859_abnormal_synaptic_plasticity | 1.31809796 |
| 45 | MP0005084_abnormal_gallbladder_morpholo | 1.31418062 |
| 46 | MP0001765_abnormal_ion_homeostasis | 1.28192581 |
| 47 | MP0010352_gastrointestinal_tract_polyps | 1.26422935 |
| 48 | MP0004782_abnormal_surfactant_physiolog | 1.23860343 |
| 49 | MP0001764_abnormal_homeostasis | 1.23380650 |
| 50 | MP0005365_abnormal_bile_salt | 1.20267753 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.19181687 |
| 52 | MP0001756_abnormal_urination | 1.16202502 |
| 53 | MP0001501_abnormal_sleep_pattern | 1.15882463 |
| 54 | MP0003868_abnormal_feces_composition | 1.15668482 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.08873346 |
| 56 | MP0002876_abnormal_thyroid_physiology | 1.05687175 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.04032685 |
| 58 | MP0004858_abnormal_nervous_system | 1.03434872 |
| 59 | MP0005448_abnormal_energy_balance | 0.99943120 |
| 60 | MP0008004_abnormal_stomach_pH | 0.99136943 |
| 61 | MP0005166_decreased_susceptibility_to | 0.97470434 |
| 62 | MP0009643_abnormal_urine_homeostasis | 0.95843771 |
| 63 | MP0001188_hyperpigmentation | 0.88484747 |
| 64 | MP0000467_abnormal_esophagus_morphology | 0.87710012 |
| 65 | MP0002971_abnormal_brown_adipose | 0.87557671 |
| 66 | MP0005410_abnormal_fertilization | 0.87174855 |
| 67 | MP0004947_skin_inflammation | 0.86180555 |
| 68 | MP0002166_altered_tumor_susceptibility | 0.84514648 |
| 69 | MP0009115_abnormal_fat_cell | 0.82537170 |
| 70 | MP0002118_abnormal_lipid_homeostasis | 0.80173617 |
| 71 | MP0003453_abnormal_keratinocyte_physiol | 0.79912352 |
| 72 | MP0002734_abnormal_mechanical_nocicepti | 0.79646527 |
| 73 | MP0005636_abnormal_mineral_homeostasis | 0.77952683 |
| 74 | MP0005310_abnormal_salivary_gland | 0.77889391 |
| 75 | MP0004885_abnormal_endolymph | 0.77570528 |
| 76 | MP0006054_spinal_hemorrhage | 0.77314846 |
| 77 | MP0002098_abnormal_vibrissa_morphology | 0.77261992 |
| 78 | MP0001485_abnormal_pinna_reflex | 0.76019564 |
| 79 | MP0005666_abnormal_adipose_tissue | 0.75710446 |
| 80 | MP0009642_abnormal_blood_homeostasis | 0.75471277 |
| 81 | MP0001845_abnormal_inflammatory_respons | 0.75355335 |
| 82 | MP0000470_abnormal_stomach_morphology | 0.74923673 |
| 83 | MP0005501_abnormal_skin_physiology | 0.74778969 |
| 84 | MP0002089_abnormal_postnatal_growth/wei | 0.74466789 |
| 85 | MP0001440_abnormal_grooming_behavior | 0.73580935 |
| 86 | MP0000604_amyloidosis | 0.71563305 |
| 87 | MP0003329_amyloid_beta_deposits | 0.71027439 |
| 88 | MP0009379_abnormal_foot_pigmentation | 0.70820352 |
| 89 | MP0003436_decreased_susceptibility_to | 0.69609041 |
| 90 | MP0002896_abnormal_bone_mineralization | 0.69362111 |
| 91 | MP0000230_abnormal_systemic_arterial | 0.69277614 |
| 92 | MP0000465_gastrointestinal_hemorrhage | 0.68970007 |
| 93 | MP0002909_abnormal_adrenal_gland | 0.68473309 |
| 94 | MP0008469_abnormal_protein_level | 0.68232174 |
| 95 | MP0000249_abnormal_blood_vessel | 0.67727566 |
| 96 | MP0003718_maternal_effect | 0.67017203 |
| 97 | MP0009785_altered_susceptibility_to | 0.66058964 |
| 98 | MP0009384_cardiac_valve_regurgitation | 0.63655085 |
| 99 | MP0002234_abnormal_pharynx_morphology | 0.61236252 |
| 100 | MP0005025_abnormal_response_to | 0.60487827 |
| 101 | MP0001216_abnormal_epidermal_layer | 0.60444843 |
| 102 | MP0000678_abnormal_parathyroid_gland | 0.59205539 |
| 103 | MP0002733_abnormal_thermal_nociception | 0.58739966 |
| 104 | MP0009333_abnormal_splenocyte_physiolog | 0.58469138 |
| 105 | MP0005535_abnormal_body_temperature | 0.58273984 |
| 106 | MP0009053_abnormal_anal_canal | 0.58248357 |
| 107 | MP0003075_altered_response_to | 0.57920562 |
| 108 | MP0003045_fibrosis | 0.56718174 |
| 109 | MP0003635_abnormal_synaptic_transmissio | 0.56189391 |
| 110 | MP0005257_abnormal_intraocular_pressure | 0.55916454 |
| 111 | MP0002254_reproductive_system_inflammat | 0.55887612 |
| 112 | MP0005332_abnormal_amino_acid | 0.54078778 |
| 113 | MP0003724_increased_susceptibility_to | 0.53944799 |
| 114 | MP0003953_abnormal_hormone_level | 0.53855704 |
| 115 | MP0005451_abnormal_body_composition | 0.53036696 |
| 116 | MP0002078_abnormal_glucose_homeostasis | 0.52631586 |
| 117 | MP0003950_abnormal_plasma_membrane | 0.52402094 |
| 118 | MP0003806_abnormal_nucleotide_metabolis | 0.52240396 |
| 119 | MP0003303_peritoneal_inflammation | 0.52201096 |
| 120 | MP0004484_altered_response_of | 0.51400131 |
| 121 | MP0003638_abnormal_response/metabolism_ | 0.48594990 |
| 122 | MP0002006_tumorigenesis | 0.48033631 |
| 123 | MP0005165_increased_susceptibility_to | 0.47057164 |
| 124 | MP0001486_abnormal_startle_reflex | 0.47002102 |
| 125 | MP0002132_abnormal_respiratory_system | 0.45753512 |
| 126 | MP0005023_abnormal_wound_healing | 0.44942278 |
| 127 | MP0009745_abnormal_behavioral_response | 0.44928647 |
| 128 | MP0004185_abnormal_adipocyte_glucose | 0.44618031 |
| 129 | MP0001970_abnormal_pain_threshold | 0.44406226 |
| 130 | MP0002136_abnormal_kidney_physiology | 0.44234672 |
| 131 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.43389138 |
| 132 | MP0005319_abnormal_enzyme/_coenzyme | 0.41866792 |
| 133 | MP0000609_abnormal_liver_physiology | 0.40868343 |
| 134 | MP0008873_increased_physiological_sensi | 0.40370871 |
| 135 | MP0002063_abnormal_learning/memory/cond | 0.40300803 |
| 136 | MP0008569_lethality_at_weaning | 0.39845001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ileus (HP:0002595) | 7.66182317 |
| 2 | Right ventricular cardiomyopathy (HP:0011663) | 5.68827739 |
| 3 | Malnutrition (HP:0004395) | 5.18627326 |
| 4 | Acanthocytosis (HP:0001927) | 4.82380325 |
| 5 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.78124816 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 4.72636566 |
| 7 | Cupped ribs (HP:0000887) | 4.66396110 |
| 8 | Flat acetabular roof (HP:0003180) | 4.33711477 |
| 9 | Abdominal distention (HP:0003270) | 4.22657382 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.04089239 |
| 11 | Hemorrhage of the eye (HP:0011885) | 4.04088787 |
| 12 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.98147758 |
| 13 | Villous atrophy (HP:0011473) | 3.98147758 |
| 14 | Hyperactive renin-angiotensin system (HP:0000841) | 3.84523292 |
| 15 | Conjugated hyperbilirubinemia (HP:0002908) | 3.76682229 |
| 16 | Abnormality of the 1st metacarpal (HP:0010009) | 3.74296432 |
| 17 | Metabolic alkalosis (HP:0200114) | 3.70813959 |
| 18 | Hypobetalipoproteinemia (HP:0003563) | 3.70018988 |
| 19 | Xanthomatosis (HP:0000991) | 3.61533329 |
| 20 | Hydroxyprolinuria (HP:0003080) | 3.57124178 |
| 21 | Abnormality of proline metabolism (HP:0010907) | 3.57124178 |
| 22 | Complement deficiency (HP:0004431) | 3.42829474 |
| 23 | Widely patent fontanelles and sutures (HP:0004492) | 3.42539211 |
| 24 | Ventricular fibrillation (HP:0001663) | 3.34548014 |
| 25 | Chronic diarrhea (HP:0002028) | 3.28825308 |
| 26 | Pustule (HP:0200039) | 3.28626571 |
| 27 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 3.28494600 |
| 28 | Glomerulonephritis (HP:0000099) | 3.27718514 |
| 29 | Alkalosis (HP:0001948) | 3.26770324 |
| 30 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 3.16236148 |
| 31 | Abnormality of complement system (HP:0005339) | 3.16148876 |
| 32 | Progressive sensorineural hearing impairment (HP:0000408) | 3.13789683 |
| 33 | Hyperglycinuria (HP:0003108) | 3.12495549 |
| 34 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.05985248 |
| 35 | Pili torti (HP:0003777) | 3.05201827 |
| 36 | Dehydration (HP:0001944) | 2.99310175 |
| 37 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.96541374 |
| 38 | Congenital sensorineural hearing impairment (HP:0008527) | 2.95908045 |
| 39 | Deep venous thrombosis (HP:0002625) | 2.95900907 |
| 40 | Abnormal tarsal ossification (HP:0008369) | 2.94779278 |
| 41 | Proximal tubulopathy (HP:0000114) | 2.94550084 |
| 42 | Milia (HP:0001056) | 2.94075136 |
| 43 | Gastrointestinal dysmotility (HP:0002579) | 2.93728985 |
| 44 | Nausea (HP:0002018) | 2.89743122 |
| 45 | Syncope (HP:0001279) | 2.87813200 |
| 46 | Hyperuricemia (HP:0002149) | 2.85292865 |
| 47 | Increased purine levels (HP:0004368) | 2.85292865 |
| 48 | Autoimmune thrombocytopenia (HP:0001973) | 2.83486248 |
| 49 | Focal segmental glomerulosclerosis (HP:0000097) | 2.79013651 |
| 50 | Fat malabsorption (HP:0002630) | 2.78496451 |
| 51 | Abnormality of glycine metabolism (HP:0010895) | 2.77815521 |
| 52 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.77815521 |
| 53 | Abnormality of chloride homeostasis (HP:0011422) | 2.77160290 |
| 54 | Progressive hearing impairment (HP:0001730) | 2.75424068 |
| 55 | Abnormality of vitamin B metabolism (HP:0004340) | 2.75125801 |
| 56 | Fragile nails (HP:0001808) | 2.75069720 |
| 57 | Abnormality of carpal bone ossification (HP:0006257) | 2.67119285 |
| 58 | Myokymia (HP:0002411) | 2.60185271 |
| 59 | Short phalanx of the thumb (HP:0009660) | 2.59817940 |
| 60 | Neonatal short-limb short stature (HP:0008921) | 2.59447377 |
| 61 | Hypotension (HP:0002615) | 2.59020886 |
| 62 | Bundle branch block (HP:0011710) | 2.53071520 |
| 63 | Steatorrhea (HP:0002570) | 2.52566135 |
| 64 | Woolly hair (HP:0002224) | 2.52308856 |
| 65 | Hypolipoproteinemia (HP:0010981) | 2.51071244 |
| 66 | Hypophosphatemia (HP:0002148) | 2.50973325 |
| 67 | Micronodular cirrhosis (HP:0001413) | 2.49699711 |
| 68 | Poikilocytosis (HP:0004447) | 2.49600994 |
| 69 | Abnormality of renin-angiotensin system (HP:0000847) | 2.49024127 |
| 70 | Nephritis (HP:0000123) | 2.48112574 |
| 71 | Gout (HP:0001997) | 2.47256682 |
| 72 | Hyperammonemia (HP:0001987) | 2.46398201 |
| 73 | Palpitations (HP:0001962) | 2.44838951 |
| 74 | Abnormal biliary tract morphology (HP:0012440) | 2.41028740 |
| 75 | Potter facies (HP:0002009) | 2.37561531 |
| 76 | Facial shape deformation (HP:0011334) | 2.37561531 |
| 77 | Abnormality of vitamin metabolism (HP:0100508) | 2.35400826 |
| 78 | Glomerulosclerosis (HP:0000096) | 2.35311965 |
| 79 | Hyperparathyroidism (HP:0000843) | 2.34869704 |
| 80 | Abnormality of purine metabolism (HP:0004352) | 2.33410349 |
| 81 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.31133712 |
| 82 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.30466379 |
| 83 | Autoimmune hemolytic anemia (HP:0001890) | 2.29738866 |
| 84 | Cholecystitis (HP:0001082) | 2.27712614 |
| 85 | Abnormal gallbladder physiology (HP:0012438) | 2.27712614 |
| 86 | Alopecia of scalp (HP:0002293) | 2.26939592 |
| 87 | Goiter (HP:0000853) | 2.26537168 |
| 88 | Pigmentary retinal degeneration (HP:0001146) | 2.26442042 |
| 89 | Abnormality of nucleobase metabolism (HP:0010932) | 2.25946759 |
| 90 | Intrahepatic cholestasis (HP:0001406) | 2.25937541 |
| 91 | Onycholysis (HP:0001806) | 2.25561566 |
| 92 | Abnormality of the 2nd finger (HP:0004100) | 2.25164974 |
| 93 | Biliary tract neoplasm (HP:0100574) | 2.25022002 |
| 94 | Ureteral stenosis (HP:0000071) | 2.24131220 |
| 95 | Thin bony cortex (HP:0002753) | 2.23387260 |
| 96 | Abnormality of the gastric mucosa (HP:0004295) | 2.20572026 |
| 97 | Hoarse voice (HP:0001609) | 2.20243502 |
| 98 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.19338074 |
| 99 | Atrophic scars (HP:0001075) | 2.19135808 |
| 100 | Flattened epiphyses (HP:0003071) | 2.19100254 |
| 101 | Decreased circulating renin level (HP:0003351) | 2.18002661 |
| 102 | Plantar hyperkeratosis (HP:0007556) | 2.17721325 |
| 103 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.15910832 |
| 104 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.12109050 |
| 105 | Prolonged QT interval (HP:0001657) | 2.11197449 |
| 106 | Subcapsular cataract (HP:0000523) | 2.11116412 |
| 107 | Epidermoid cyst (HP:0200040) | 2.09838315 |
| 108 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.09662564 |
| 109 | Enlarged epiphyses (HP:0010580) | 2.08878685 |
| 110 | Abnormal hand bone ossification (HP:0010660) | 2.07852829 |
| 111 | Fragile skin (HP:0001030) | 2.07794618 |
| 112 | Megaloblastic anemia (HP:0001889) | 2.07778950 |
| 113 | Eczematoid dermatitis (HP:0000976) | 2.05998813 |
| 114 | Delayed epiphyseal ossification (HP:0002663) | 2.04902610 |
| 115 | Ureteral obstruction (HP:0006000) | 2.03836157 |
| 116 | Protuberant abdomen (HP:0001538) | 2.03717952 |
| 117 | Abnormality of urine glucose concentration (HP:0011016) | 2.00160235 |
| 118 | Glycosuria (HP:0003076) | 2.00160235 |
| 119 | Confusion (HP:0001289) | 1.99838254 |
| 120 | Male infertility (HP:0003251) | 1.99723028 |
| 121 | Curly hair (HP:0002212) | 1.99196881 |
| 122 | Late onset (HP:0003584) | 1.98447295 |
| 123 | Hyperaldosteronism (HP:0000859) | 1.98230836 |
| 124 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.98122931 |
| 125 | Ventricular arrhythmia (HP:0004308) | 1.97388220 |
| 126 | Abnormal urine phosphate concentration (HP:0012599) | 1.97083065 |
| 127 | Renal tubular acidosis (HP:0001947) | 1.97033257 |
| 128 | Hypoplasia of dental enamel (HP:0006297) | 1.96886558 |
| 129 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.96680463 |
| 130 | Vascular calcification (HP:0004934) | 1.95768556 |
| 131 | Cerebral palsy (HP:0100021) | 1.95548657 |
| 132 | Pancreatitis (HP:0001733) | 1.94597596 |
| 133 | Rectal prolapse (HP:0002035) | 1.94030578 |
| 134 | Cone-rod dystrophy (HP:0000548) | 1.93818672 |
| 135 | Abnormal hair laboratory examination (HP:0003328) | 1.93054163 |
| 136 | Abnormal ossification of hand bones (HP:0005921) | 1.92297321 |
| 137 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.92175727 |
| 138 | Wide cranial sutures (HP:0010537) | 1.92091640 |
| 139 | Abnormal foot bone ossification (HP:0010675) | 1.92038209 |
| 140 | Myopathic facies (HP:0002058) | 1.89265912 |
| 141 | Growth hormone excess (HP:0000845) | 1.89203653 |
| 142 | Polygenic inheritance (HP:0010982) | 1.88851585 |
| 143 | Hyperphosphatemia (HP:0002905) | 1.88693789 |
| 144 | Abnormality of the costochondral junction (HP:0000919) | 1.86761121 |
| 145 | Nephrolithiasis (HP:0000787) | 1.86750553 |
| 146 | Dicarboxylic aciduria (HP:0003215) | 1.84446703 |
| 147 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84446703 |
| 148 | Hyperphosphaturia (HP:0003109) | 1.82124854 |
| 149 | Metabolic acidosis (HP:0001942) | 1.81792933 |
| 150 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.78995772 |
| 151 | Posterior subcapsular cataract (HP:0007787) | 1.76021572 |
| 152 | Hyponatremia (HP:0002902) | 1.74744638 |
| 153 | Hypokalemia (HP:0002900) | 1.73852125 |
| 154 | Abnormality of potassium homeostasis (HP:0011042) | 1.71406519 |
| 155 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.70674129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 5.54981936 |
| 2 | ACVR1B | 5.13588533 |
| 3 | FRK | 4.91689755 |
| 4 | PIK3CA | 4.50244592 |
| 5 | LMTK2 | 4.32225700 |
| 6 | FGFR4 | 3.32452404 |
| 7 | RIPK1 | 3.17501193 |
| 8 | MAP2K2 | 3.17064993 |
| 9 | NME1 | 3.16783826 |
| 10 | MST4 | 3.14913191 |
| 11 | MAP3K2 | 3.02374433 |
| 12 | KSR2 | 2.81249511 |
| 13 | PRKG2 | 2.57270608 |
| 14 | TAOK3 | 2.52266453 |
| 15 | TAOK1 | 2.19260746 |
| 16 | EPHB2 | 2.02334347 |
| 17 | GRK6 | 1.95522523 |
| 18 | MET | 1.86663266 |
| 19 | TESK1 | 1.85092119 |
| 20 | FGFR3 | 1.72986684 |
| 21 | MAP3K9 | 1.71444568 |
| 22 | EPHA2 | 1.51889315 |
| 23 | DDR2 | 1.35832375 |
| 24 | PTK6 | 1.34863929 |
| 25 | MAP2K1 | 1.32138677 |
| 26 | EPHA4 | 1.29895152 |
| 27 | TYK2 | 1.28860566 |
| 28 | MAP3K12 | 1.23402628 |
| 29 | STK24 | 1.21473943 |
| 30 | SIK1 | 1.18406259 |
| 31 | RIPK4 | 1.16323313 |
| 32 | TRIB3 | 1.13717508 |
| 33 | MAP3K1 | 1.10069632 |
| 34 | MAP2K6 | 1.07834791 |
| 35 | MYLK | 1.05080035 |
| 36 | PRKD3 | 1.03834485 |
| 37 | MATK | 1.03593554 |
| 38 | CAMK2D | 1.03072844 |
| 39 | MAP4K1 | 1.01884796 |
| 40 | EPHA3 | 0.99907939 |
| 41 | DYRK1B | 0.98904620 |
| 42 | PTK2 | 0.97927230 |
| 43 | PDGFRA | 0.95753107 |
| 44 | IRAK3 | 0.91710469 |
| 45 | PDK2 | 0.79508932 |
| 46 | MAP3K8 | 0.77693564 |
| 47 | DMPK | 0.77629087 |
| 48 | PRKCI | 0.77197495 |
| 49 | PRPF4B | 0.76947706 |
| 50 | PDPK1 | 0.76326716 |
| 51 | AKT3 | 0.74914560 |
| 52 | ICK | 0.74817482 |
| 53 | NUAK1 | 0.73486154 |
| 54 | TBK1 | 0.72194963 |
| 55 | PDK4 | 0.71484680 |
| 56 | PDK3 | 0.71484680 |
| 57 | ERBB2 | 0.70375725 |
| 58 | TESK2 | 0.70124884 |
| 59 | ERN1 | 0.69841109 |
| 60 | ARAF | 0.66698133 |
| 61 | MAP3K10 | 0.66624096 |
| 62 | MAP3K7 | 0.66598560 |
| 63 | FER | 0.62751821 |
| 64 | PDK1 | 0.62410349 |
| 65 | SMG1 | 0.62114899 |
| 66 | MAP3K11 | 0.61025425 |
| 67 | NTRK3 | 0.60997536 |
| 68 | CAMK2B | 0.60214440 |
| 69 | TYRO3 | 0.59136476 |
| 70 | CAMKK1 | 0.58987816 |
| 71 | CAMK2G | 0.55793239 |
| 72 | TTK | 0.54071871 |
| 73 | STK39 | 0.52181881 |
| 74 | ZAP70 | 0.51801563 |
| 75 | CDK5 | 0.49891825 |
| 76 | STK10 | 0.49863697 |
| 77 | STK11 | 0.49608641 |
| 78 | TNIK | 0.49200668 |
| 79 | ERBB4 | 0.48023534 |
| 80 | LIMK1 | 0.47368854 |
| 81 | OXSR1 | 0.45822656 |
| 82 | NLK | 0.45751830 |
| 83 | BRAF | 0.45329054 |
| 84 | CSF1R | 0.44722787 |
| 85 | PRKAA2 | 0.44422713 |
| 86 | PRKCA | 0.43622058 |
| 87 | CDC42BPA | 0.41709304 |
| 88 | WNK4 | 0.41406948 |
| 89 | PRKCZ | 0.40440198 |
| 90 | IRAK1 | 0.38595184 |
| 91 | PAK3 | 0.38241362 |
| 92 | SRC | 0.37989783 |
| 93 | MAPK11 | 0.37882227 |
| 94 | BMX | 0.37495736 |
| 95 | PAK4 | 0.36439061 |
| 96 | PTK2B | 0.36021739 |
| 97 | MUSK | 0.35642663 |
| 98 | PKN2 | 0.34688413 |
| 99 | RET | 0.34263876 |
| 100 | EEF2K | 0.32722142 |
| 101 | EPHB1 | 0.32066555 |
| 102 | PAK6 | 0.30943884 |
| 103 | MAP3K3 | 0.30007967 |
| 104 | CDK15 | 0.28842837 |
| 105 | CAMK2A | 0.28626118 |
| 106 | PRKAA1 | 0.28424557 |
| 107 | CDK18 | 0.26257235 |
| 108 | JAK1 | 0.26055512 |
| 109 | ROCK1 | 0.25961594 |
| 110 | MINK1 | 0.24815700 |
| 111 | PDGFRB | 0.24754288 |
| 112 | ABL2 | 0.24524486 |
| 113 | KSR1 | 0.24457822 |
| 114 | CDK11A | 0.24347514 |
| 115 | CSNK1A1 | 0.24035150 |
| 116 | CDK19 | 0.23912313 |
| 117 | FGR | 0.23632991 |
| 118 | FYN | 0.23460659 |
| 119 | YES1 | 0.23204441 |
| 120 | PIK3CG | 0.22770066 |
| 121 | CSK | 0.22452877 |
| 122 | FGFR1 | 0.21541364 |
| 123 | CDK9 | 0.21400421 |
| 124 | DAPK2 | 0.21223855 |
| 125 | WNK1 | 0.21213123 |
| 126 | MAPKAPK2 | 0.21135685 |
| 127 | IGF1R | 0.21129661 |
| 128 | MAP3K13 | 0.20972894 |
| 129 | PRKACG | 0.20779236 |
| 130 | TAOK2 | 0.20422045 |
| 131 | CDK6 | 0.20220884 |
| 132 | PRKCD | 0.19257188 |
| 133 | PAK1 | 0.19012160 |
| 134 | ITK | 0.18209570 |
| 135 | MAP3K4 | 0.17857231 |
| 136 | IRAK4 | 0.17700224 |
| 137 | IKBKE | 0.17698862 |
| 138 | JAK2 | 0.17139024 |
| 139 | MAP3K6 | 0.15951955 |
| 140 | MELK | 0.14601723 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 4.67898498 |
| 2 | Mineral absorption_Homo sapiens_hsa04978 | 4.29340023 |
| 3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.01250770 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.88686309 |
| 5 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.94820134 |
| 6 | Bile secretion_Homo sapiens_hsa04976 | 2.72635502 |
| 7 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.49544217 |
| 8 | Galactose metabolism_Homo sapiens_hsa00052 | 2.22735366 |
| 9 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.20475576 |
| 10 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.19055432 |
| 11 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.02764844 |
| 12 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.92268100 |
| 13 | Retinol metabolism_Homo sapiens_hsa00830 | 1.77126950 |
| 14 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.71394931 |
| 15 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.70515237 |
| 16 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.65240031 |
| 17 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.61470364 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.61251375 |
| 19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.57418361 |
| 20 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.43168574 |
| 21 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.42285367 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.39632994 |
| 23 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.38704299 |
| 24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.34974371 |
| 25 | Salivary secretion_Homo sapiens_hsa04970 | 1.32697415 |
| 26 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.28780159 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.27317795 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.26787982 |
| 29 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.25929559 |
| 30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.20587910 |
| 31 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.19123973 |
| 32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.18685720 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.18508418 |
| 34 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.18343115 |
| 35 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.12475168 |
| 36 | Tight junction_Homo sapiens_hsa04530 | 1.12171590 |
| 37 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06645104 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.05679013 |
| 39 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04900244 |
| 40 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.02580231 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.02177251 |
| 42 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.01708588 |
| 43 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.00602046 |
| 44 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.99337380 |
| 45 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.96183136 |
| 46 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.95571716 |
| 47 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.94946189 |
| 48 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.91404012 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87836116 |
| 50 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.84519905 |
| 51 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.84011129 |
| 52 | Asthma_Homo sapiens_hsa05310 | 0.83004883 |
| 53 | Insulin secretion_Homo sapiens_hsa04911 | 0.80866576 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80504476 |
| 55 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.72254022 |
| 56 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.71275774 |
| 57 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.71082998 |
| 58 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.69964494 |
| 59 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.69936303 |
| 60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68687743 |
| 61 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67940807 |
| 62 | Sulfur relay system_Homo sapiens_hsa04122 | 0.67894502 |
| 63 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.67396974 |
| 64 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.65115580 |
| 65 | ABC transporters_Homo sapiens_hsa02010 | 0.63699940 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.62451476 |
| 67 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.60509315 |
| 68 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59499347 |
| 69 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59399752 |
| 70 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.58675371 |
| 71 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58658653 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58649236 |
| 73 | Allograft rejection_Homo sapiens_hsa05330 | 0.56311672 |
| 74 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56268447 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.54631048 |
| 76 | Bladder cancer_Homo sapiens_hsa05219 | 0.53747958 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.53529571 |
| 78 | Peroxisome_Homo sapiens_hsa04146 | 0.52920418 |
| 79 | Thyroid cancer_Homo sapiens_hsa05216 | 0.52911547 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.52016015 |
| 81 | Gap junction_Homo sapiens_hsa04540 | 0.50960637 |
| 82 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.50631507 |
| 83 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.48039924 |
| 84 | Hepatitis C_Homo sapiens_hsa05160 | 0.47761255 |
| 85 | Long-term potentiation_Homo sapiens_hsa04720 | 0.47539445 |
| 86 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.46866347 |
| 87 | Circadian entrainment_Homo sapiens_hsa04713 | 0.46811709 |
| 88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46474287 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.46074212 |
| 90 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.44934875 |
| 91 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.43779227 |
| 92 | Cocaine addiction_Homo sapiens_hsa05030 | 0.43484455 |
| 93 | Carbon metabolism_Homo sapiens_hsa01200 | 0.43330120 |
| 94 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.43131556 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42935197 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42478810 |
| 97 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.41109534 |
| 98 | Long-term depression_Homo sapiens_hsa04730 | 0.40765130 |
| 99 | Alzheimers disease_Homo sapiens_hsa05010 | 0.40667497 |
| 100 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.40638629 |
| 101 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40533646 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.40052291 |
| 103 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.39379696 |
| 104 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39320696 |
| 105 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.39296733 |
| 106 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.37175627 |
| 107 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.36442768 |
| 108 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.36340463 |
| 109 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.36040305 |
| 110 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.36035575 |
| 111 | Pertussis_Homo sapiens_hsa05133 | 0.34076016 |
| 112 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.34057656 |
| 113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28139557 |
| 114 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.27642378 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.24969871 |
| 116 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.24627425 |
| 117 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.23771633 |
| 118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.22814315 |
| 119 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22696978 |
| 120 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.22521826 |
| 121 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.21880267 |
| 122 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.21795707 |
| 123 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.21604040 |
| 124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.20728521 |
| 125 | Leishmaniasis_Homo sapiens_hsa05140 | 0.20160274 |
| 126 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.20144115 |
| 127 | Adherens junction_Homo sapiens_hsa04520 | 0.19352072 |
| 128 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.18849380 |
| 129 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.18807696 |
| 130 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.18344736 |
| 131 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.15081492 |
| 132 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.14840748 |
| 133 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.10217154 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.09804162 |
| 135 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.08495069 |
| 136 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.07487713 |
| 137 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.05378010 |
| 138 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.05091314 |
| 139 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.04664780 |
| 140 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.04127295 |

